Exact Mass: 331.1696

Exact Mass Matches: 331.1696

Found 179 metabolites which its exact mass value is equals to given mass value 331.1696, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetramethrin

2,2-Dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylic acid, ester with N-(hydroxymethyl)-1-cyclo hexene 1,2-dicarboximide

C19H25NO4 (331.1783)


P - Antiparasitic products, insecticides and repellents > P03 - Ectoparasiticides, incl. scabicides, insecticides and repellents > P03B - Insecticides and repellents > P03BA - Pyrethrines D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins D016573 - Agrochemicals

   

Bucharaine

CBMicro_015380

C19H25NO4 (331.1783)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 1.132 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.131 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.129 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.128

   

Erythratidine

Erythratidine

C19H25NO4 (331.1783)


   
   

Salmefamol

1-(4-Hydroxy-3-(hydroxymethyl)phenyl)-2-(4-methoxy-alpha-methylphenethylamino)ethanol

C19H25NO4 (331.1783)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

O-Methyllycorenine

O-Methyllycorenine

C19H25NO4 (331.1783)


   

Pandamarilactone 31

6-methoxy-6-methyl-1-{4-[(2E)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}-1H,2H,3H,4H,5H,6H,7H-cyclopenta[b]pyridin-5-one

C19H25NO4 (331.1783)


Pandamarilactone 31 is a food flavouring. Pandamarilactone 31 is an alkaloid from leaves of Pandanus amaryllifolius. Food flavouring. Alkaloid from leaves of Pandanus amaryllifolius

   

6-Hydroxyoct-2-enedioylcarnitine

3-[(7-carboxy-6-hydroxyhept-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.1631)


6-hydroxyoct-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyoct-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyoct-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-hydroxyoct-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyoct-3-enedioylcarnitine

3-[(7-carboxy-6-hydroxyhept-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.1631)


6-hydroxyoct-3-enedioylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyoct-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyoct-3-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-hydroxyoct-3-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyoct-3-enedioylcarnitine

3-[(7-carboxy-7-hydroxyhept-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.1631)


7-hydroxyoct-3-enedioylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyoct-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-hydroxyoct-3-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-hydroxyoct-3-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyoct-4-enedioylcarnitine

3-[(7-carboxy-7-hydroxyhept-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.1631)


7-hydroxyoct-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyoct-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-hydroxyoct-4-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-hydroxyoct-4-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxyoct-2-enedioylcarnitine

3-[(7-carboxy-5-hydroxyhept-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.1631)


5-hydroxyoct-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxyoct-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-hydroxyoct-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-hydroxyoct-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Cocapropylene

3-Benzoyloxy-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid propyl ester

C19H25NO4 (331.1783)


   
   
   
   

NBOMe-mescaline

NBOMe-mescaline

C19H25NO4 (331.1783)


   
   

(-)-misramine

(-)-misramine

C19H25NO4 (331.1783)


   

Galanthamine, 3-O-acetyl-1,2-dihydro-

Galanthamine, 3-O-acetyl-1,2-dihydro-

C19H25NO4 (331.1783)


   

(-)-roehybrine

(-)-roehybrine

C19H25NO4 (331.1783)


   

Acetylknightinol

Acetylknightinol

C19H25NO4 (331.1783)


   
   

SCHEMBL1972292

SCHEMBL1972292

C19H25NO4 (331.1783)


   

N-(3,4-Dimethoxybenzyl)-2-(3,4-dimethoxyphenyl)ethanamine

N-(3,4-Dimethoxybenzyl)-2-(3,4-dimethoxyphenyl)ethanamine

C19H25NO4 (331.1783)


   

2-hydroxyisotaxodine|2-hydroxytaxodine

2-hydroxyisotaxodine|2-hydroxytaxodine

C19H25NO4 (331.1783)


   

2-Hydroxyisotaxodine

2-Hydroxyisotaxodine

C19H25NO4 (331.1783)


   

(-)-O-methylpapyramine|O-Methylpapyramine

(-)-O-methylpapyramine|O-Methylpapyramine

C19H25NO4 (331.1783)


   

Aad(-Ala-D-Val)|L,L,D-alpha-aminodipoyl-alanyl-valine

Aad(-Ala-D-Val)|L,L,D-alpha-aminodipoyl-alanyl-valine

C14H25N3O6 (331.1743)


   

O-Acetylmesembrenol

O-Acetylmesembrenol

C19H25NO4 (331.1783)


   

Chingchengenamide B

Chingchengenamide B

C19H25NO4 (331.1783)


   

15,16-ethane-1,2-diyldioxy-3beta-methoxy-(6xi)-erythrinan-2alpha-ol|Erythratin

15,16-ethane-1,2-diyldioxy-3beta-methoxy-(6xi)-erythrinan-2alpha-ol|Erythratin

C19H25NO4 (331.1783)


   
   
   

lycopladine C

lycopladine C

C19H25NO4 (331.1783)


   
   

12-methoxy-kesselringane-2,11beta-diol|Kesselringin|kesselringine|O-Methyl-kesselringin

12-methoxy-kesselringane-2,11beta-diol|Kesselringin|kesselringine|O-Methyl-kesselringin

C19H25NO4 (331.1783)


   

SCHEMBL4761599

SCHEMBL4761599

C19H25NO4 (331.1783)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

DIHYDROSINOMENINE

7(R)-7,8-Dihydrosinomenine

C19H25NO4 (331.1783)


   

Lotusine hydroxide

Lotusine (hydroxide)

C19H25NO4 (331.1783)


Lotusine (hydroxide) is a pure alkaloid extracted from the green seed embryo of Nelumbo nucifera Gaertn. Lotusine (hydroxide) shows effects on the action potentials in myocardium and slow inward current in cardiac Purkinje fibers[1].

   

BUCHARAINE

NCGC00017368-03!BUCHARAINE

C19H25NO4 (331.1783)


   

2-[2-[(2-acetamido-4-methylpentanoyl)amino]propanoylamino]-3-hydroxypropanoic acid

NCGC00347880-02!2-[2-[(2-acetamido-4-methylpentanoyl)amino]propanoylamino]-3-hydroxypropanoic acid

C14H25N3O6 (331.1743)


   
   

2-[2-[(2-acetamido-4-methylpentanoyl)amino]propanoylamino]-3-hydroxypropanoic acid [IIN-based on: CCMSLIB00000847807]

NCGC00347880-02!2-[2-[(2-acetamido-4-methylpentanoyl)amino]propanoylamino]-3-hydroxypropanoic acid [IIN-based on: CCMSLIB00000847807]

C14H25N3O6 (331.1743)


   

2-[2-[(2-acetamido-4-methylpentanoyl)amino]propanoylamino]-3-hydroxypropanoic acid [IIN-based: Match]

NCGC00347880-02!2-[2-[(2-acetamido-4-methylpentanoyl)amino]propanoylamino]-3-hydroxypropanoic acid [IIN-based: Match]

C14H25N3O6 (331.1743)


   
   
   
   
   
   
   
   

Pandamarilactone 31

6-methoxy-6-methyl-1-{4-[(2E)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}-1H,2H,3H,4H,5H,6H,7H-cyclopenta[b]pyridin-5-one

C19H25NO4 (331.1783)


   

N-Acetylleucylalanylserine

N-Acetylleucylalanylserine

C14H25N3O6 (331.1743)


   

4-[(3-acetoxypropyl)amino]-2,2-dimethyl-4-oxobutane-1,3-diyl diacetate

4-[(3-acetoxypropyl)amino]-2,2-dimethyl-4-oxobutane-1,3-diyl diacetate

C15H25NO7 (331.1631)


   

4-N-BOC-SPIRO-INDANE-PIPERIDINE-3-CARBOXYLIC ACID

4-N-BOC-SPIRO-INDANE-PIPERIDINE-3-CARBOXYLIC ACID

C19H25NO4 (331.1783)


   

4-(4-benzylpiperidin-1-yl)quinazoline-6-carbaldehyde

4-(4-benzylpiperidin-1-yl)quinazoline-6-carbaldehyde

C21H21N3O (331.1685)


   

tert-Butyl 4-(3-oxo-3-phenylpropanoyl)piperidine-1-carboxylate

tert-Butyl 4-(3-oxo-3-phenylpropanoyl)piperidine-1-carboxylate

C19H25NO4 (331.1783)


   

Uracil,6-amino-5-[2-(benzylmethylamino)acetamido]-1,3-dimethyl- (6CI)

Uracil,6-amino-5-[2-(benzylmethylamino)acetamido]-1,3-dimethyl- (6CI)

C16H21N5O3 (331.1644)


   

3-DIMETHYLAMINO-2-[1-(4-METHOXY-BENZYL)-1H-TETRAZOL-5-YL]-ACRYLIC ACID ETHYL ESTER

3-DIMETHYLAMINO-2-[1-(4-METHOXY-BENZYL)-1H-TETRAZOL-5-YL]-ACRYLIC ACID ETHYL ESTER

C16H21N5O3 (331.1644)


   

1-Benzyl 3-ethyl 3-allyl-1,3-piperidinedicarboxylate

1-Benzyl 3-ethyl 3-allyl-1,3-piperidinedicarboxylate

C19H25NO4 (331.1783)


   

d-tetramethrin

d-tetramethrin

C19H25NO4 (331.1783)


   

3-DIMETHYLAMINO-2-[2-(4-METHOXY-BENZYL)-2H-TETRAZOL-5-YL]-ACRYLIC ACID ETHYL ESTER

3-DIMETHYLAMINO-2-[2-(4-METHOXY-BENZYL)-2H-TETRAZOL-5-YL]-ACRYLIC ACID ETHYL ESTER

C16H21N5O3 (331.1644)


   

1-(4-TOLUENENSULFONYLAMINO)-2,6-DIISOPROPYLBENZENE

1-(4-TOLUENENSULFONYLAMINO)-2,6-DIISOPROPYLBENZENE

C19H25NO2S (331.1606)


   

2-Phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline

2-Phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline

C21H22BNO2 (331.1744)


   

ethyl 3-[1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]indol-2-yl]propanoate

ethyl 3-[1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]indol-2-yl]propanoate

C19H25NO4 (331.1783)


   

TERT-BUTYL 2-(2-ETHOXY-1,1-DIMETHYL-2-OXOETHYL)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 2-(2-ETHOXY-1,1-DIMETHYL-2-OXOETHYL)-1H-INDOLE-1-CARBOXYLATE

C19H25NO4 (331.1783)


   
   

ETHYL 4-(BENZYLOXYCARBONYLAMINO)BICYCLO[2.2.2]OCTANE-1-CARBOXYLATE

ETHYL 4-(BENZYLOXYCARBONYLAMINO)BICYCLO[2.2.2]OCTANE-1-CARBOXYLATE

C19H25NO4 (331.1783)


   

solanapyrone C

solanapyrone C

C19H25NO4 (331.1783)


   

N-(6-Ethyl-1-oxoindan-4-ylcarbonyl)isoleucine methyl ester

N-(6-Ethyl-1-oxoindan-4-ylcarbonyl)isoleucine methyl ester

C19H25NO4 (331.1783)


   

(3E)-3-[(2S)-1-hydroxy-2,4-dimethylhexylidene]-5-[(4-hydroxyphenyl)methyl]pyrrolidine-2,4-dione

(3E)-3-[(2S)-1-hydroxy-2,4-dimethylhexylidene]-5-[(4-hydroxyphenyl)methyl]pyrrolidine-2,4-dione

C19H25NO4 (331.1783)


   

6-Hydroxyoct-2-enedioylcarnitine

6-Hydroxyoct-2-enedioylcarnitine

C15H25NO7 (331.1631)


   

6-Hydroxyoct-3-enedioylcarnitine

6-Hydroxyoct-3-enedioylcarnitine

C15H25NO7 (331.1631)


   

7-Hydroxyoct-3-enedioylcarnitine

7-Hydroxyoct-3-enedioylcarnitine

C15H25NO7 (331.1631)


   

7-Hydroxyoct-4-enedioylcarnitine

7-Hydroxyoct-4-enedioylcarnitine

C15H25NO7 (331.1631)


   

5-Hydroxyoct-2-enedioylcarnitine

5-Hydroxyoct-2-enedioylcarnitine

C15H25NO7 (331.1631)


   

3-(2,6-Dimethylpiperidin-1-yl)-5-{(E)-[hydroxy(4-methoxyphenyl)methylidene]amino}-1,2,3-oxadiazol-3-ium

3-(2,6-Dimethylpiperidin-1-yl)-5-{(E)-[hydroxy(4-methoxyphenyl)methylidene]amino}-1,2,3-oxadiazol-3-ium

C17H23N4O3+ (331.177)


   

1-(3-Methoxyphenyl)-3-[(1,7,7-trimethylnorbornan-2-ylidene)amino]thiourea

1-(3-Methoxyphenyl)-3-[(1,7,7-trimethylnorbornan-2-ylidene)amino]thiourea

C18H25N3OS (331.1718)


   

N-[4-(1-piperidinyl)phenyl]-2-quinolinecarboxamide

N-[4-(1-piperidinyl)phenyl]-2-quinolinecarboxamide

C21H21N3O (331.1685)


   

2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-morpholinyl)-5-pyrimidinecarboxylic acid ethyl ester

2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-morpholinyl)-5-pyrimidinecarboxylic acid ethyl ester

C16H21N5O3 (331.1644)


   

5-(4-Methylpiperidin-1-yl)-2-(naphthalen-1-ylmethyl)-1,3-oxazole-4-carbonitrile

5-(4-Methylpiperidin-1-yl)-2-(naphthalen-1-ylmethyl)-1,3-oxazole-4-carbonitrile

C21H21N3O (331.1685)


   

6-[2-(1-azepanyl)-2-oxoethoxy]-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-one

6-[2-(1-azepanyl)-2-oxoethoxy]-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-one

C19H25NO4 (331.1783)


   

(1R)-tetramethrin

(1R)-tetramethrin

C19H25NO4 (331.1783)


   
   
   
   
   
   
   

4-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-2-(hydroxymethyl)phenol

4-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-2-(hydroxymethyl)phenol

C19H25NO4 (331.1783)


   
   
   
   
   
   
   
   
   
   

10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxodecanoate

10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxodecanoate

C16H27O7- (331.1757)


   

(9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxodecanoate

(9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxodecanoate

C16H27O7- (331.1757)


   

(2S)-N-[2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]ethyl]-2-methylpiperidine-1-carboxamide

(2S)-N-[2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]ethyl]-2-methylpiperidine-1-carboxamide

C18H22FN3O2 (331.1696)


   

2-[2-[(2-Acetamido-4-methylpentanoyl)amino]propanoylamino]-3-hydroxypropanoic acid

2-[2-[(2-Acetamido-4-methylpentanoyl)amino]propanoylamino]-3-hydroxypropanoic acid

C14H25N3O6 (331.1743)


   

2-Trimethylsilyloxy-N-(2-(ethylamino)ethyl)-4-quinolinecarboxamide

2-Trimethylsilyloxy-N-(2-(ethylamino)ethyl)-4-quinolinecarboxamide

C17H25N3O2Si (331.1716)


   

Tetramethrin

Tetramethrin

C19H25NO4 (331.1783)


P - Antiparasitic products, insecticides and repellents > P03 - Ectoparasiticides, incl. scabicides, insecticides and repellents > P03B - Insecticides and repellents > P03BA - Pyrethrines D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins D016573 - Agrochemicals

   

Salmefamol

4-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-2-(hydroxymethyl)phenol

C19H25NO4 (331.1783)


   

(1s,8s,10r,17s)-4,5,8-trimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene

(1s,8s,10r,17s)-4,5,8-trimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene

C19H25NO4 (331.1783)


   

[(1s)-1-[5-(1h-indol-3-yl)-1,3-oxazol-2-yl]-2-phenylethyl]dimethylamine

[(1s)-1-[5-(1h-indol-3-yl)-1,3-oxazol-2-yl]-2-phenylethyl]dimethylamine

C21H21N3O (331.1685)


   

6-methoxy-6-methyl-1-[4-(4-methyl-5-oxofuran-2-ylidene)butyl]-2h,3h,4h,7h-cyclopenta[b]pyridin-5-one

6-methoxy-6-methyl-1-[4-(4-methyl-5-oxofuran-2-ylidene)butyl]-2h,3h,4h,7h-cyclopenta[b]pyridin-5-one

C19H25NO4 (331.1783)


   

(3s,6e)-8-[(2-hydroxyquinolin-4-yl)oxy]-2,6-dimethyloct-6-ene-2,3-diol

(3s,6e)-8-[(2-hydroxyquinolin-4-yl)oxy]-2,6-dimethyloct-6-ene-2,3-diol

C19H25NO4 (331.1783)


   

(1s,16r,17r)-5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-4,16-diol

(1s,16r,17r)-5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-4,16-diol

C19H25NO4 (331.1783)


   

3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyltrideca-4,6,8,10-tetraenimidic acid

3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyltrideca-4,6,8,10-tetraenimidic acid

C19H25NO4 (331.1783)


   

5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-triene-4,8-diol

5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-triene-4,8-diol

C19H25NO4 (331.1783)


   

2-epierythratidine

NA

C19H25NO4 (331.1783)


{"Ingredient_id": "HBIN005581","Ingredient_name": "2-epierythratidine","Alias": "NA","Ingredient_formula": "C19H25NO4","Ingredient_Smile": "NA","Ingredient_weight": "331.41","OB_score": "NA","CAS_id": "41431-23-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8661","PubChem_id": "NA","DrugBank_id": "NA"}

   

3r*,4r*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione

NA

C19H25NO4 (331.1783)


{"Ingredient_id": "HBIN009518","Ingredient_name": "3r*,4r*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione","Alias": "NA","Ingredient_formula": "C19H25NO4","Ingredient_Smile": "CC(C)CC1C(C(=O)N(C1=O)O)C2=CC=C(C=C2)OCC=C(C)C","Ingredient_weight": "331.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10233","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "139583762","DrugBank_id": "NA"}

   

3r*,4s*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione

NA

C19H25NO4 (331.1783)


{"Ingredient_id": "HBIN009530","Ingredient_name": "3r*,4s*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione","Alias": "NA","Ingredient_formula": "C19H25NO4","Ingredient_Smile": "CC(C)CC1C(C(=O)N(C1=O)O)C2=CC=C(C=C2)OCC=C(C)C","Ingredient_weight": "331.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10234","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10336811","DrugBank_id": "NA"}

   

(6s)-6-methoxy-6-methyl-1-{4-[(2z)-4-methyl-5-oxofuran-2-ylidene]butyl}-2h,3h,4h,7h-cyclopenta[b]pyridin-5-one

(6s)-6-methoxy-6-methyl-1-{4-[(2z)-4-methyl-5-oxofuran-2-ylidene]butyl}-2h,3h,4h,7h-cyclopenta[b]pyridin-5-one

C19H25NO4 (331.1783)


   

(3r,4s)-1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrolidine-2,5-dione

(3r,4s)-1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrolidine-2,5-dione

C19H25NO4 (331.1783)


   

[3-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-2-yl](phenyl)methyl acetate

[3-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-2-yl](phenyl)methyl acetate

C19H25NO4 (331.1783)


   

(4z,6e,8e,10e)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyltrideca-4,6,8,10-tetraenimidic acid

(4z,6e,8e,10e)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyltrideca-4,6,8,10-tetraenimidic acid

C19H25NO4 (331.1783)


   

(1s,16r,17r)-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-5,16-diol

(1s,16r,17r)-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-5,16-diol

C19H25NO4 (331.1783)


   

(1s,12s,14s)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-14-yl acetate

(1s,12s,14s)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-14-yl acetate

C19H25NO4 (331.1783)


   

1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrolidine-2,5-dione

1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrolidine-2,5-dione

C19H25NO4 (331.1783)


   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-(acetyloxy)-2-phenylpropanoate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-(acetyloxy)-2-phenylpropanoate

C19H25NO4 (331.1783)


   

methyl 8-(acetyloxy)-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadeca-2,4-diene-4-carboxylate

methyl 8-(acetyloxy)-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadeca-2,4-diene-4-carboxylate

C19H25NO4 (331.1783)


   

6-[(1r,2s,4as,8as)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-[(2-hydroxyethyl)amino]-2-oxopyran-3-carbaldehyde

6-[(1r,2s,4as,8as)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-[(2-hydroxyethyl)amino]-2-oxopyran-3-carbaldehyde

C19H25NO4 (331.1783)


   

4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-5,16-diol

4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-5,16-diol

C19H25NO4 (331.1783)


   

4,5,8-trimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene

4,5,8-trimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene

C19H25NO4 (331.1783)


   

(1s,17s)-5,6-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2,4,6,14-tetraene-4,17-diol

(1s,17s)-5,6-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2,4,6,14-tetraene-4,17-diol

C19H25NO4 (331.1783)


   

(1r,4s,13r,14s)-10,13-dimethoxy-5-methyl-12-oxa-5-azapentacyclo[11.3.1.1¹,⁴.0²,¹¹.0³,⁸]octadeca-2(11),3(8),9-trien-14-ol

(1r,4s,13r,14s)-10,13-dimethoxy-5-methyl-12-oxa-5-azapentacyclo[11.3.1.1¹,⁴.0²,¹¹.0³,⁸]octadeca-2(11),3(8),9-trien-14-ol

C19H25NO4 (331.1783)


   

(s)-[(1r,2s,3r,5s)-3-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-2-yl](phenyl)methyl acetate

(s)-[(1r,2s,3r,5s)-3-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-2-yl](phenyl)methyl acetate

C19H25NO4 (331.1783)


   

7,8,11-trimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-12-ol

7,8,11-trimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-12-ol

C19H25NO4 (331.1783)


   

(6s)-6-methoxy-6-methyl-1-{4-[(2e)-4-methyl-5-oxofuran-2-ylidene]butyl}-2h,3h,4h,7h-cyclopenta[b]pyridin-5-one

(6s)-6-methoxy-6-methyl-1-{4-[(2e)-4-methyl-5-oxofuran-2-ylidene]butyl}-2h,3h,4h,7h-cyclopenta[b]pyridin-5-one

C19H25NO4 (331.1783)


   

(4e,6e,8e,10e)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyltrideca-4,6,8,10-tetraenimidic acid

(4e,6e,8e,10e)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyltrideca-4,6,8,10-tetraenimidic acid

C19H25NO4 (331.1783)


   

(9bs,11r,12r)-7,8,11-trimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-12-ol

(9bs,11r,12r)-7,8,11-trimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-12-ol

C19H25NO4 (331.1783)


   

(5r)-1,5-dihydroxy-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-(2-methylpropyl)-5h-pyrrol-2-one

(5r)-1,5-dihydroxy-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-(2-methylpropyl)-5h-pyrrol-2-one

C19H25NO4 (331.1783)


   

(4r,5r,14r)-5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-triene-4,8-diol

(4r,5r,14r)-5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-triene-4,8-diol

C19H25NO4 (331.1783)


   

1-[(1r)-1-(dimethylamino)-2-phenylethyl]-9h-pyrido[3,4-b]indol-6-ol

1-[(1r)-1-(dimethylamino)-2-phenylethyl]-9h-pyrido[3,4-b]indol-6-ol

C21H21N3O (331.1685)


   

(1s,3s,4's)-11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-trien-4-one

(1s,3s,4's)-11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-trien-4-one

C19H25NO4 (331.1783)


   

4-[(2-hydroxyethyl)amino]-6-(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)-2-oxopyran-3-carbaldehyde

4-[(2-hydroxyethyl)amino]-6-(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)-2-oxopyran-3-carbaldehyde

C19H25NO4 (331.1783)


   

(1r,3s,4's)-11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-trien-4-one

(1r,3s,4's)-11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-trien-4-one

C19H25NO4 (331.1783)


   

(1s,16s,17r)-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-5,16-diol

(1s,16s,17r)-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-5,16-diol

C19H25NO4 (331.1783)


   

6,7-dihydroxy-2,6,10-trimethyl-12-oxo-12-(1h-pyrrol-2-yl)dodeca-2,8,10-trienal

6,7-dihydroxy-2,6,10-trimethyl-12-oxo-12-(1h-pyrrol-2-yl)dodeca-2,8,10-trienal

C19H25NO4 (331.1783)


   

7'-hydroxy-3,9'-dimethoxy-3'-methyl-11'-azaspiro[cyclohexane-1,6'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),7',9'-trien-4-one

7'-hydroxy-3,9'-dimethoxy-3'-methyl-11'-azaspiro[cyclohexane-1,6'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),7',9'-trien-4-one

C19H25NO4 (331.1783)


   

(1r,8r,10s,17r)-4,5,8-trimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene

(1r,8r,10s,17r)-4,5,8-trimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene

C19H25NO4 (331.1783)


   

(1r,12s)-4,5,8,12-tetramethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene

(1r,12s)-4,5,8,12-tetramethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene

C19H25NO4 (331.1783)


   

11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-trien-4-one

11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-trien-4-one

C19H25NO4 (331.1783)


   

methyl (1s,6r,8s,9s)-8-(acetyloxy)-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadeca-2,4-diene-4-carboxylate

methyl (1s,6r,8s,9s)-8-(acetyloxy)-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadeca-2,4-diene-4-carboxylate

C19H25NO4 (331.1783)


   

(2e,8e,10z)-6,7-dihydroxy-2,6,10-trimethyl-12-oxo-12-(1h-pyrrol-2-yl)dodeca-2,8,10-trienal

(2e,8e,10z)-6,7-dihydroxy-2,6,10-trimethyl-12-oxo-12-(1h-pyrrol-2-yl)dodeca-2,8,10-trienal

C19H25NO4 (331.1783)


   

(3s)-8-[(2-hydroxyquinolin-4-yl)oxy]-2,6-dimethyloct-6-ene-2,3-diol

(3s)-8-[(2-hydroxyquinolin-4-yl)oxy]-2,6-dimethyloct-6-ene-2,3-diol

C19H25NO4 (331.1783)


   

(1s,4s,5s,14r)-5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-triene-4,8-diol

(1s,4s,5s,14r)-5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-triene-4,8-diol

C19H25NO4 (331.1783)


   

5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-4,16-diol

5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-4,16-diol

C19H25NO4 (331.1783)


   

1,5-dihydroxy-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-(2-methylpropyl)-5h-pyrrol-2-one

1,5-dihydroxy-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-(2-methylpropyl)-5h-pyrrol-2-one

C19H25NO4 (331.1783)


   

6-[(1s,2r,4as,8as)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-[(2-hydroxyethyl)amino]-2-oxopyran-3-carbaldehyde

6-[(1s,2r,4as,8as)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-[(2-hydroxyethyl)amino]-2-oxopyran-3-carbaldehyde

C19H25NO4 (331.1783)


   

(3r,4r)-1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrolidine-2,5-dione

(3r,4r)-1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrolidine-2,5-dione

C19H25NO4 (331.1783)


   

(3s,4r)-1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrolidine-2,5-dione

(3s,4r)-1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrolidine-2,5-dione

C19H25NO4 (331.1783)


   

(1s,4s,13r,14r)-10,13-dimethoxy-5-methyl-12-oxa-5-azapentacyclo[11.3.1.1¹,⁴.0²,¹¹.0³,⁸]octadeca-2(11),3(8),9-trien-14-ol

(1s,4s,13r,14r)-10,13-dimethoxy-5-methyl-12-oxa-5-azapentacyclo[11.3.1.1¹,⁴.0²,¹¹.0³,⁸]octadeca-2(11),3(8),9-trien-14-ol

C19H25NO4 (331.1783)


   

10,13-dimethoxy-5-methyl-12-oxa-5-azapentacyclo[11.3.1.1¹,⁴.0²,¹¹.0³,⁸]octadeca-2(11),3(8),9-trien-14-ol

10,13-dimethoxy-5-methyl-12-oxa-5-azapentacyclo[11.3.1.1¹,⁴.0²,¹¹.0³,⁸]octadeca-2(11),3(8),9-trien-14-ol

C19H25NO4 (331.1783)


   

5,6-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2,4,6,14-tetraene-4,17-diol

5,6-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2,4,6,14-tetraene-4,17-diol

C19H25NO4 (331.1783)